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Abstract
Meningitis is commonly caused by a viral, bacterial, fungal, or parasitic infection that involves the cerebrospinal fluid (CSF) and
leads to inflammation of the protective membranes covering the brain and spinal cord. Among bacterial pathogens responsible for
meningitis, Streptococcus pneumoniae is notorious for causing more than 50% of all cases of bacterial meningitis. Neisseria meningitis
is also a major cause of bacterial meningitis. Here, we report a rare case of a 13-month-old infant with cardiac dysfunction associated
with meningitis caused by co-infection with Streptococcus pneumoniae and Neisseria meningitides. Cardiac dysfunction is a condition
where the heart pumping becomes less effective and the heart cannot pump sufficient blood to meet the body’s needs. Bacteria were
isolated by culture and detected by polymerase chain reaction (PCR) on CSF. The patient was treated with vancomycin, ceftriaxone,
and rifampin followed by three months of follow-up without any clinical symptoms. This raises the possibility of finding other cases
of mixed neonatal meningitis in the future since the incidence of meningitis is currently increasing in the region.
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1. Introduction
N. meningitis and S. pneumoniae are the major causes
of bacterial meningitis. There are actually five types of
meningitis including bacterial, viral, parasitic, fungal, and
non-infectious each categorized based on the etiology of
the disease. Common causes of bacterial meningitis dif-
fer by age group as follows: newborns: Group B Streptococ-
cus, Streptococcus pneumoniae, Listeria monocytogenes, and
Escherichia coli; toddlers and children: Streptococcus pneu-
moniae, Neisseria meningitides, Haemophilus influenza type
b (Hib), and group B Streptococcus; older adults: Strepto-
coccus pneumoniae, Neisseria meningitides, Haemophilus in-
fluenza type b, group B Streptococcus, and Listeria monocyto-
genes; and teens and young adults: Neisseria meningitides
and Streptococcus pneumoniae (1).
While S. pneumoniae causes more than 50% of cases
of bacterial meningitis, N. meningitides is an endemic
pathogen with the infection rate of 1 - 12 per 100,000 peo-
ple (2). Data show that the epidemiology of meningitis has
considerably changed, while S. pneumoniae is still the most
common cause of bacterial meningitis in infants, children,
and adults. However, infection with S. pneumoniae has now
been controlled in the developed countries due to success-
ful vaccination strategies (1).
On the other hand, pneumococci have been reported
to be among the most important causes of bacterial
meningitis in the US and Europe. The incidence rate of the
disease varies between 1.1 and 2 in 100,000 cases per year
in the US and Western Europe and up to 12 in 100,000 peo-
ple per year in Africa (3, 4). In Iran, the incidence rates of S.
pneumoniae infection in children under 10 years of age and
individuals aged more than 10 years old were 36% (95% CI;
31 - 40) and 20% (95% CI; 13 - 27), respectively (5). Nonethe-
less, there is an important dissimilarity in the prevalence
of these two sub-groups.
The high prevalence rate of S. pneumoniae in Iran
is troubling due to the appearance of drug resistant
strains, particularly those resistant to third-generation
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cephalosporins and penicillin (5). Meningococci cause
acute diseases in children, elderlies, splenectomised pa-
tients, and those with malnutrition or sickle cell disease
(6). The reason for the increasing incidence of meningo-
coccal diseases is the rising prevalence of S. pneumoniae
strains resistant to multiple antibiotics (7). We report a
rare case of an infant with cardiac dysfunction and menin-
gitis caused by S. pneumoniae and N. meningitides in Iran.
2. Case Presentation
A 13-month-old infant from western Tehran with no
history of meningococcal polysaccharide vaccination was
hospitalised due to cardiac dysfunction (congestive heart
failure). The patient presented with fever, frequent vomit-
ing, cough, and diarrhoea with a normal level of conscious-
ness. On physical examination, pharyngitis, and neck stiff-
ness were observed. The patient had normal immune sys-
tem and no immune system dysfunction was observed.
The baby had several small purple lesions in the upper and
lower limbs and in the trunk region, but there were no clin-
ical symptoms in the eyes or ears.
The patient was hospitalised in intensive care unit
(ICU) because of sepsis or meningitis. Lumbar punc-
ture was performed for diagnostic tests, and blood was
collected for general and special laboratory examina-
tions. Laboratory results showed white blood cell count
of 18000/mm3 composed of 72% neutrophils, 20% lympho-
cytes, 5% monocytes, 3% eosinophils, and total protein was
68 mg/dL and C-reactive protein was 160.5 mg/L. The level
of glucose in CSF was 35 mg/dL. CSF was macroscopically
colourless and semi-clear. In CSF, WBC count was 23,500
WBC/mm3. Gram staining of CSF was also performed and
showed very rare gram-positive cocci and gram-negative
diplococci. CSF was then cultured on Trypticase soy agar
and broth (Biomed, France) and blood-chocolate agar, and
then it was incubated at 37°C with 5% CO2. Cultures of CSF
demonstrated mixed growth of oxidase-positive, gram-
negative diplococci, and catalase-negative, gram-positive
cocci. The two organisms were further detected as N.
meningitides and S. pneumoniae.
The S. pneumoniae isolate was recognised on the ba-
sis of an 18-mm diameter inhibitory zone around the op-
tochin disk (BBL Taxo discs; Becton Dickinson Company,
Sparks, MD) after incubation in a CO2-enriched atmo-
sphere. This detection was confirmed by using a poly-
merase chain reaction (PCR) test. Based on the initial re-
sults and possibility of susceptibility to penicillin, empir-
ical therapy was started with ceftriaxone (100 mg/kg of
body weight/day) and vancomycin (128 mg 8 hourly). Fur-
ther confirmation for S. pneumonia and N. meningitidis was
obtained by antibiogram test (Optochin) and PCR (Figures
1 and 2) (8, 9).
Figure 1. Amplification of a 348-bp DNA fragment of the ply gene from S. pneumonia
Figure 2. Amplification of a 600-bp DNA fragment of Men1 gene from N. meningitidis
Optochin disk test showed an 18-mm-diameter inhi-
bition zone (5 ug/disk) on optochin (Becton Dickinson,
Sparks, Mass). Antimicrobial susceptibility was deter-
mined by minimum inhibitory concentration (MIC) and
disk diffusion methods using Mueller-Hinton agar (Hime-
2 Arch Clin Infect Dis. 2018; 13(6):e65270.
Mohammad Nejad AA et al.
dia) supplemented with 5% sheep blood. We used pure cul-
ture of chocolate agar with inoculum corrected to 0.5 Mc-
Farland standards. Test condition was based on Clinical
and Laboratory Standards Institute (CLSI). S. pneumoniae
ATCC 49619 and Escherichia coli ATCC 25922 were used as
controls.
Susceptibility tests indicated that the isolated bacte-
ria were susceptible to oxacillin, vancomycin, gentamicin,
erythromycin, rifampicin, clindamycin, and doxycycline,
but resistant to penicillin (MIC, 4 mg/L), ceftriaxone (2
mg/L), and cefotaxime (2 mg/L). Adding the rifampin to
the therapeutic regimen resulted in the significant clini-
cal improvement. Then, the patient was discharged. The
patient’s follow-up showed no further clinical symptoms.
Written informed consent was obtained from the patient’s
mother for publication of this case report.
3. Discussion
The first case of meningitis caused by two or more bac-
terial infections was reported in the 1900s (10). The ma-
jority of the reported cases of meningitis till 1950 were
caused by S. pneumoniae, N. meningitides, H. influenza type
b, and Branhamella catarrhalis (10). There are several factors
that can increase the risk of bacterial meningitis including
age, community health care settings, medical conditions,
working with meningitis pathogens, and travel. On the
other hand, in one-third of patients with bacterial menin-
gitis, there are predisposing conditions such as immunod-
eficiency. Splenectomy, alcoholism, HIV, diabetes mellitus,
cancer, or the use of immunosuppressive medications are
the known risk factors related to invasive bacterial infec-
tions, including meningitis (4, 11, 12). For example, one of
the most common organisms causing bacterial meningi-
tis in immunocompromised patients is S. pneumoniae, al-
though patients with specific risk factors could also be ex-
posed to pathogenic organisms (13).
Susceptibility to meningitis is particularly raised in pa-
tients with leukaemia and lymphoma; one-fourth of all
central nervous system infections in cancer patients occur
in this group. Patients with cancer, who have recently expe-
rienced neurosurgery, are also at risk for meningitis (14).
Dysfunction or removal of the spleen render people sus-
ceptible to infections with encapsulated bacteria such as
S. pneumoniae and Haemophilus influenzae. Hyposplenism
and splenectomy are two unusual risk factors for bacterial
meningitis associated with a high rate of mortality (15).
Based on the normal immune system in this patient,
the possibility of defects in the immune system was re-
jected (6). In this case, age, neglect, and cardiac dysfunc-
tion may be considered the important risk factors in de-
veloping this mixed meningitis. This was the first study
in Iran that reported S. pneumoniae and N. meningitides
isolated from a patient with cardiac dysfunction. In this
case, although antibiotics were administrated (ceftriax-
one), treatment delay and antibiotic resistance were the
main issues in response to treatment. This could be be-
cause of incorrect and irregular use of antibiotics by pri-
vate and/or government clinicians in Iran.
In this study, rash were noted in the patient with-
out necrosis of the skin or purpura fulminans. In severe
cases, rash may rapidly develop into petechiae, purpura
fulminans, and necrosis of the skin and underlying tis-
sues with thrombosis (16). In this patient, CSF pleocytosis
was not seen while the absence of CSF pleocytosis in inva-
sive meningococcal disease (IMD) has been linked to an in-
creased risk of death.
Examination of the CSF WBC count is one of the impor-
tant tools for the assessment of an infant with suspected
CNS infection. However, mild pleocytosis can be observed
in symptomatic infants without CNS infection. Lack of CSF
pleocytosis can represent a prognostic factor (17). In the
patient reported here, rifampin plus vancomycin did not
cause major changes in the activity of either drug alone,
but it was more effective than ceftriaxone. This case rep-
resents a physical disability that can increase the risk of
meningitis. Due to the increasing emergence of penicillin-
resistant pneumococci and the increasing clinical failure
of cephalosporins, a change in treatment for S. pneumoniae
was recommended by the Clinical and Laboratory Stan-
dards Institute in 2015 (18).
Currently, ceftriaxone or cefotaxime with vancomycin
are recommended as the first-line regimens for empir-
ical treatment of S. pneumonia meningitis (7, 19). The
major antibiotics in our study were rifampin and van-
comycin. Due to the increased rate of penicillin resistance,
cephalosporins and third-generation cephalosporins such
as ceftriaxone are currently considered a good choice for
the initial therapy against N. meningitidis and S. pneumo-
niae (7, 19, 20). However, in this study, due to bacterial
resistance, ceftriaxone was ineffective against meningitis
and the treatment was therefore switched to rifampin and
vancomycin. Hypoglycaemia has rarely been linked to se-
vere infection, except in cases of malaria and shigellosis.
There are a few case reports on the occurrence severe sep-
sis caused by the encapsulated bacteria, including Strepto-
coccus pneumoniae, Haemophilus influenzae, and Neisseria
meningitidis (21). Hypoglycaemia in meningitis increases
the risk of complications such as seizure and brain dam-
age (22, 23). It has therefore been recommended that in ad-
dition to other laboratory examinations, blood sugar must
be checked. Molecular techniques are useful for distin-
guishing between bacteria. In this study, all methods in-
cluding a molecular method (PCR) and examinations for
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accurate and rapid bacterial diagnosis were adopted.
3.1. Conclusion
In sum, meningitis is usually caused by single infection
with S. pneumoniae, N. meningitides, or H. influenza. How-
ever, we reported an exceptional case of meningitis caused
by S. pneumonia and N. meningitides with cardiac dysfunc-
tion.
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